Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.
Varettoni M, Mangiacavalli S, Rattotti S, Cartia CS, Cavalloni C, Rossetti F, Ferretti VV, Bergamini F, Trotti C, Fiorelli N, Pagani G, Zerbi C, Ferrari J, Cristinelli C, Muzzi A, Marena C, Baldanti F, Bruno R, Arcaini L. Varettoni M, et al. Among authors: cavalloni c. Leuk Lymphoma. 2021 Dec;62(13):3311-3312. doi: 10.1080/10428194.2021.1953019. Epub 2021 Jul 14. Leuk Lymphoma. 2021. PMID: 34261423 No abstract available.
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.
Arcaini L, Zibellini S, Boveri E, Riboni R, Rattotti S, Varettoni M, Guerrera ML, Lucioni M, Tenore A, Merli M, Rizzi S, Morello L, Cavalloni C, Da Vià MC, Paulli M, Cazzola M. Arcaini L, et al. Among authors: cavalloni c. Blood. 2012 Jan 5;119(1):188-91. doi: 10.1182/blood-2011-08-368209. Epub 2011 Nov 9. Blood. 2012. PMID: 22072557 Free article.
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.
Rumi E, Harutyunyan AS, Pietra D, Milosevic JD, Casetti IC, Bellini M, Them NC, Cavalloni C, Ferretti VV, Milanesi C, Berg T, Sant'Antonio E, Boveri E, Pascutto C, Astori C, Kralovics R, Cazzola M; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators. Rumi E, et al. Among authors: cavalloni c. Blood. 2014 Apr 10;123(15):2416-9. doi: 10.1182/blood-2014-01-550434. Epub 2014 Feb 19. Blood. 2014. PMID: 24553179 Free article.
Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia.
Rumi E, Bertozzi I, Casetti IC, Roncoroni E, Cavalloni C, Bellini M, Sant'Antonio E, Gotti M, Ferretti VV, Milanesi C, Peroni E, Pietra D, Astori C, Randi ML, Cazzola M; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators. Rumi E, et al. Among authors: cavalloni c. Haematologica. 2015 Nov;100(11):e443-5. doi: 10.3324/haematol.2015.131458. Epub 2015 Aug 6. Haematologica. 2015. PMID: 26250575 Free PMC article. No abstract available.
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.
Pietra D, Rumi E, Ferretti VV, Di Buduo CA, Milanesi C, Cavalloni C, Sant'Antonio E, Abbonante V, Moccia F, Casetti IC, Bellini M, Renna MC, Roncoroni E, Fugazza E, Astori C, Boveri E, Rosti V, Barosi G, Balduini A, Cazzola M. Pietra D, et al. Among authors: cavalloni c. Leukemia. 2016 Feb;30(2):431-8. doi: 10.1038/leu.2015.277. Epub 2015 Oct 9. Leukemia. 2016. PMID: 26449662 Free PMC article.
Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria.
Rumi E, Boveri E, Bellini M, Pietra D, Ferretti VV, Sant'Antonio E, Cavalloni C, Casetti IC, Roncoroni E, Ciboddo M, Benvenuti P, Landini B, Fugazza E, Troletti D, Astori C, Cazzola M; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators. Rumi E, et al. Among authors: cavalloni c. Oncotarget. 2017 Oct 6;8(60):101735-101744. doi: 10.18632/oncotarget.21594. eCollection 2017 Nov 24. Oncotarget. 2017. PMID: 29254200 Free PMC article.
Diagnosis and management of prefibrotic myelofibrosis.
Rumi E, Sant'Antonio E, Boveri E, Pietra D, Cavalloni C, Roncoroni E, Astori C, Arcaini L; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators. Rumi E, et al. Among authors: cavalloni c. Expert Rev Hematol. 2018 Jul;11(7):537-545. doi: 10.1080/17474086.2018.1484280. Epub 2018 Jun 22. Expert Rev Hematol. 2018. PMID: 29862872 Review.
Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms.
Rumi E, Zibellini S, Boveri E, Cavalloni C, Riboni R, Casetti IC, Ciboddo M, Trotti C, Favaron C, Pietra D, Candido C, Ferretti VV, Cazzola M, Arcaini L. Rumi E, et al. Among authors: cavalloni c. Am J Hematol. 2019 Jul;94(7):E185-E188. doi: 10.1002/ajh.25489. Epub 2019 May 1. Am J Hematol. 2019. PMID: 30972817 Free article. Clinical Trial. No abstract available.
Facing erythrocytosis: Results of an international physician survey.
Rumi E, McMullin MF, Harrison C, Ellis MH, Barzilai M, Sarid N, Mesa R, Paoli C, Angona A, Sant'Antonio E, Ferretti VV, Cavalloni C, Casetti IC, Trotti C, Barbui T. Rumi E, et al. Among authors: cavalloni c. Am J Hematol. 2019 Sep;94(9):E225-E227. doi: 10.1002/ajh.25545. Epub 2019 Jun 10. Am J Hematol. 2019. PMID: 31148218 Free PMC article. No abstract available.
32 results